Fermeture percutanée de l'auricule gauche: un nouvel espoir pour le patient en fibrillation auriculaire [Percutaneous closure of left atrial appendage: a new hope for patients with atrial fibrillation?].


Autoria(s): Girod G.; Delabays A.; Eeckhout E.; Fromer M.; Monney P.; Vogt P.; Pruvot E.
Data(s)

2013

Resumo

Atrial fibrillation (AF) is the most common cardiac arrhythmia. The risk of thromboembolic events is important, and at that time, there is no definite treatment for AF. Oral anticoagulation also represents a hemorrhagic risk factor. Ninety percent of atrial thrombi are located within the left atrial appendage. The percutaneous closure of this left atrial appendage with a device has been shown to decrease thromboembolic events even after interruption of oral anticoagulation as compared to warfarin in a recent randomized study. Recent data support this innovative technique as a reasonable alternative to long term anticoagulation in patients at high risk of bleeding.

Identificador

http://serval.unil.ch/?id=serval:BIB_D47879764F41

isbn:1660-9379 (Print)

pmid:23469402

http://my.unil.ch/serval/document/BIB_D47879764F41.pdf

http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D47879764F415

Idioma(s)

fr

Direitos

info:eu-repo/semantics/openAccess

Fonte

Revue Médicale Suisse, vol. 9, no. 372, pp. 332-336

Palavras-Chave #Atrial Appendage/surgery; Atrial Fibrillation/complications; Cardiac Surgical Procedures/methods; Humans; Risk; Thromboembolism/etiology; Thromboembolism/prevention & control
Tipo

info:eu-repo/semantics/review

article